Endonovo Therapeutics, Inc. (ENDV) stock
ENDVOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2023, quarter ended Sep 30, 2023Last filing: 10-Q/A on Dec 29, 2023
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $135.08KP/E –Yield –
Endonovo Therapeutics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Endonovo Therapeutics's ebitda for the twelve months ending Dec 31, 2022 was -$2.62M. For fiscal 2022 it was -$2.62M. The highest annual figure on record is -$77.02K in fiscal 2010.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -$2.62M | – |
| FY2021 | Dec 31, 2021 | -$1.58M | – |
| FY2020 | Dec 31, 2020 | -$2.26M | – |
| FY2019 | Dec 31, 2019 | -$3.16M | – |
| FY2018 | Dec 31, 2018 | -$3.51M | – |
| FY2017 | Dec 31, 2017 | -$4.59M | – |
| FY2016 | Dec 31, 2016 | -$5.40M | – |
| FY2015 | Dec 31, 2015 | -$2.55M | – |
| FY2014 | Dec 31, 2014 | -$2.18M | – |
| FY2013 | Dec 31, 2013 | -$2.42M | – |
| FY2012 | Dec 31, 2012 | -$1.71M | – |
| FY2011 | Dec 31, 2011 | -$94.55K | – |
| FY2010 | Dec 31, 2010 | -$77.02K | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2023 | Sep 30, 2023 | -$311.07K | – |
| Q4 FY2022 | Dec 31, 2022 | -$321.32K | – |
| Q3 FY2022 | Sep 30, 2022 | -$335.05K | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.64M | – |
| Q1 FY2022 | Mar 31, 2022 | -$324.03K | – |
| Q4 FY2021 | Dec 31, 2021 | -$212.07K | – |
| Q3 FY2021 | Sep 30, 2021 | -$530.53K | – |
| Q2 FY2021 | Jun 30, 2021 | -$408.33K | – |
| Q1 FY2021 | Mar 31, 2021 | -$427.14K | – |
| Q4 FY2020 | Dec 31, 2020 | -$521.33K | – |
| Q3 FY2020 | Sep 30, 2020 | -$783.24K | – |
| Q2 FY2020 | Jun 30, 2020 | -$440.13K | – |
| Q1 FY2020 | Mar 31, 2020 | -$516.26K | – |
| Q4 FY2019 | Dec 31, 2019 | -$567.37K | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.13M | – |
| Q2 FY2019 | Jun 30, 2019 | -$812.24K | – |
| Q1 FY2019 | Mar 31, 2019 | -$650.52K | – |
| Q4 FY2018 | Dec 31, 2018 | -$869.31K | – |
| Q3 FY2018 | Sep 30, 2018 | -$872.48K | – |
| Q2 FY2018 | Jun 30, 2018 | -$653.92K | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.11M | – |
| Q4 FY2017 | Dec 31, 2017 | -$829.27K | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.03M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.17M | – |
| Q1 FY2017 | Mar 31, 2017 | -$553.82K | – |
| Q4 FY2016 | Dec 31, 2016 | -$628.86K | – |
| Q1 FY2016 | Jun 30, 2016 | -$3.46M | – |
| Q1 FY2015 | Mar 31, 2015 | -$427.99K | – |
| Q4 FY2014 | Dec 31, 2014 | -$167.33K | – |
| Q3 FY2014 | Sep 30, 2014 | -$628.95K | – |
| Q2 FY2014 | Jun 30, 2014 | -$815.25K | – |
| Q1 FY2014 | Mar 31, 2014 | -$563.95K | – |
| Q4 FY2013 | Dec 31, 2013 | -$496.38K | – |
| Q3 FY2013 | Sep 30, 2013 | -$418.31K | – |
| Q2 FY2013 | Jun 30, 2013 | -$480.36K | – |
| Q1 FY2013 | Mar 31, 2013 | -$1.02M | – |
See a number that looks wrong?